India, June 17 -- Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced the launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single Dose Vial.Glenmark's Methylene Blue Injection USP is bioequivalent and therapeutically equivalent to the reference listed drug, ProvayBlue' Injection, 50 mg/10 mL (5 mg/mL), of Provepharm SAS [NDA 204630].
Published by HT Digital Content Services with permission from Pivotal Sources....